Arada’s AED 2 billion Reem Hospital deal targets 800 UAE beds

Arada plans a UAE healthcare network of close to 800 beds after buying more than 80% of Reem Hospital and committing AED 2 billion to expansion.

For private hospital CEOs, CFOs and COOs, the immediate issue is capacity: Arada is pairing a real estate balance sheet with an Abu Dhabi-licensed hospital platform and residential catchments in Dubai and Sharjah.

What Arada bought

The deal gives Arada control of Reem Hospital, a Reem Island provider that opened in 2020 and has more than 800 employees. Zawya reported that the seller group included Investcorp and affiliated shareholders. Financial terms for the stake were not disclosed.

Reem Hospital is expected to double its current facility to 200 beds. The plan also calls for new hospitals in Abu Dhabi, Dubai and Sharjah, plus a Reem Clinics network across the UAE, with some sites inside Arada master-planned communities.

• AED 2 billion committed to the acquisition and expansion plan.
• More than 80% of Reem Hospital acquired by Arada.
• 200 beds planned at the existing Reem Island facility.
• Three new hospitals planned in Abu Dhabi, Dubai and Sharjah.

Why operators should care

Arada changes the competitive map by tying hospital capacity to residential catchments. Its communities include Aljada in Sharjah and Jouri Hills in Dubai. Clinics inside those developments could feed diagnostics, rehabilitation, women’s health and paediatrics into Reem Hospital and future sites.

For CFOs, the question is whether the AED 2 billion budget creates price pressure in mid-acuity specialties. Reem Hospital treated more than 850,000 patients in 2025, according to regional coverage of the transaction. If the new hospitals scale quickly, incumbent groups could face harder insurer talks in Abu Dhabi and Dubai, especially in rehabilitation, orthopaedics, cardiology, women’s health and paediatrics.

COOs face the staffing problem first. A network moving toward 800 beds will need physicians, nurses, allied health workers, coders and revenue-cycle staff across at least three emirates. Licensing, privileging and facility commissioning will run through the Department of Health Abu Dhabi (DOH), the Dubai Health Authority (DHA) and the Ministry of Health and Prevention (MOHAP), depending on site location.

The regulatory test

Abu Dhabi is the likely first expansion step because Reem Hospital already operates under DOH and has a management team in place. Dubai is the tougher private-hospital market, with established operators such as Mediclinic, Aster DM Healthcare, NMC Healthcare and Saudi German Health. Sharjah gives Arada a route through MOHAP-regulated capacity near its own residential base.

Medical directors should watch how Arada handles women’s health, paediatrics, oncology and cardiology across sites. DOH, DHA and MOHAP each approve physician scope, facility type and quality controls before services begin. A hospital brand can be national, but licences remain local.

The number to remember is 800 beds. Aster DM Healthcare has announced AED 1 billion of UAE expansion by 2028, and Arada’s AED 2 billion plan adds a developer-owned competitor to the same market. Operators should track the first new site approval, the payer contracts attached to it and the hiring pattern in nursing and allied health during 2026.